Riskpilot← Back to searchSign inGet full accessHolsun Medical AB
ABActiveOrg 5568882830Vulcanusgatan 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20121 employees
Revenue 2025
SEK 2,7M
+16% vs 2024
EBITDA margin
31.3%
+37% vs 2024
Equity ratio
41.5%
Financial strength
Net profit 2025
SEK 630K
+37% vs 2024
| Revenue | SEK 2,7M | +16% |
| EBITDA | SEK 832K | +37% |
| Net profit | SEK 630K | +37% |
| Total assets | SEK 2M | +32% |
| Equity | SEK 837K | +38% |
| Employees | 1 | — |
Legal name
Holsun Medical AB
Org number
5568882830
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 mars 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall bedriva partihandel med medicinsk utrustning och konsultverksamhet avseende företags organisation samt därmed förenlig verksamhet.
Address
Vulcanusgatan 1
Email
tomsundelin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9 | 0 | 1 864 | 2 302 | 2 662 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −48 | 213 | 578 | 609 | 832 |
| Depreciation & amort. | −0 | −0 | −30 | −30 | −30 |
| EBIT | −48 | 213 | 548 | 579 | 802 |
| Net financials | — | — | −6 | — | −1 |
| Profit before tax | −48 | 213 | 541 | 579 | 801 |
| Tax | −0 | −44 | −113 | −120 | −171 |
| Net profit | −48 | 169 | 428 | 459 | 630 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 101 | 401 | 1 161 | 1 526 | 2 016 |
| Equity | 101 | 269 | 498 | 606 | 837 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 131 | 663 | 920 | 1 179 |
| Total debt | — | 131 | 663 | 920 | 1 179 |
EBITDA margin
31.3%
This company
15.8%
Market median
+98% vs market
20212025
Equity ratio
41.5%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
75.3%
This company
18.4%
Market median
+309% vs market
20212025
Net profit margin
23.7%
This company
8.1%
Market median
+193% vs market
20212025
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TÅ Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Holsun Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Åke Gunnar Sundelin | Chief Executive Officer | 0 companies |
| Carl Martin Hansson | Deputy Board Member | 0 companies |
| Krister Edwin Sjöberg | Chairman | 0 companies |